Literature DB >> 10492528

Measurement of acute phase proteins in the rat brain: contribution of vascular contents.

D A Loeffler1, M C Linder, M Zamany, E Harel, M A Paul, H Baumann, P A LeWitt.   

Abstract

A localized acute phase response occurs in the brain in Alzheimer's disease. Acute phase proteins have previously been measured in brain homogenates to quantify this response. The extent to which measurements of these proteins reflect brain parenchymal contents, as opposed to vascular contents, is unknown. In this study, the acute phase proteins ceruloplasmin (CP), complement factor 3 (C3), haptoglobin (HP), and albumin were measured in regional brain homogenates from phosphate buffered saline-perfused and sham-perfused rats (n = 7-9/group). Interleukin 1-beta (IL1-beta) and copper were also measured. Mean CP, C3, HP, and albumin concentrations in perfused specimens decreased by 94%, 88%, 90%, and 81% vs. sham-perfused specimens (all p < 0.001), while IL1-beta and copper were unchanged. These results suggest that acute phase protein measurements in brain homogenates reflect primarily vascular contents. However, IL1-beta and copper concentrations in brain homogenates are minimally influenced by vascular contents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492528     DOI: 10.1023/a:1020989426694

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

1.  Complement activation in amyloid plaques in Alzheimer's dementia.

Authors:  P Eikelenboom; C E Hack; J M Rozemuller; F C Stam
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

Review 2.  Stimulation of hepatic acute phase response by cytokines and glucocorticoids.

Authors:  H Baumann; K R Prowse; S Marinković; K A Won; G P Jahreis
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

3.  Electrophoretic analysis of acute-phase plasma proteins.

Authors:  H Baumann
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Neurons express proteins of the classical complement pathway in Alzheimer disease.

Authors:  K Terai; D G Walker; E G McGeer; P L McGeer
Journal:  Brain Res       Date:  1997-09-26       Impact factor: 3.252

5.  Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages.

Authors:  J G Sheng; R E Mrak; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1997-03       Impact factor: 3.685

6.  Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

Authors:  J Bauer; S Strauss; U Schreiter-Gasser; U Ganter; P Schlegel; I Witt; B Yolk; M Berger
Journal:  FEBS Lett       Date:  1991-07-08       Impact factor: 4.124

7.  Synthesis and turnover of ceruloplasmin in rats treated with 17 beta-estradiol.

Authors:  R B Middleton; M C Linder
Journal:  Arch Biochem Biophys       Date:  1993-05       Impact factor: 4.013

Review 8.  The protease inhibitor, alpha 1-antichymotrypsin, is a component of the brain amyloid deposits in normal aging and Alzheimer's disease.

Authors:  C R Abraham; H Potter
Journal:  Ann Med       Date:  1989       Impact factor: 4.709

9.  Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

Authors:  J A Wood; P L Wood; R Ryan; N R Graff-Radford; C Pilapil; Y Robitaille; R Quirion
Journal:  Brain Res       Date:  1993-12-03       Impact factor: 3.252

Review 10.  Copper biochemistry and molecular biology.

Authors:  M C Linder; M Hazegh-Azam
Journal:  Am J Clin Nutr       Date:  1996-05       Impact factor: 7.045

View more
  1 in total

1.  Measurement by ELISA of complement factor 4 (C4) in the rat brain: necessity for removal of cerebrovascular proteins.

Authors:  David A Loeffler; Dianne M Camp
Journal:  Neurochem Res       Date:  2006-07-18       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.